Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec 2;54(7):1438-1446.
doi: 10.55730/1300-0144.5929. eCollection 2024.

Hematological diseases and the heart

Ferda Can  1
Affiliations
Review

Hematological diseases and the heart

Ferda Can. Turk J Med Sci. .

Abstract

The heart, as the main part of the circulatory system, is one of the organs frequently affected by hematological diseases. Cardiac problems may develop during the course and treatment of benign and malignant hematological diseases. This review study was conducted based on recent information from the literature and manifestations of cardiac involvement in hematology were summarized. Determining appropriate cardiac approaches in cases of hematological diseases with relevant knowledge and experience regarding the development of cardiac involvement in pathophysiological conditions has an important role in the diagnosis and treatment processes of patients. This review provides relevant information about hematological diseases and the heart, and key points that will help in the diagnosis and treatment process are presented.

Keywords: Hematological disease; cardiac involvement; heart.

PubMed Disclaimer

Figures

Figure
Figure
Diagnostic algorithm for AL amyloidosis.
See this image and copyright information in PMC

References

    1. Ali S, Mumtaz S, Shakir HA, Khan M, Tahir HM, et al. Current status of beta-thalassemia and its treatment strategies. Molecular Genetics and Genomic Medicine. 2021;9(12):1788–1801. doi: 10.1002/mgg3.1788. - DOI - PMC - PubMed
    1. Kremastinos DT, Farmakis D, Aessopos A, Hahalis G, Hamodraka E, et al. β-thalassemia cardiomyopathy: history, present considerations, and future perspectives. Circulation Heart Failure. 2010;3(3):451–458. doi: 10.1161/CIRCHEARTFAILURE.109.913863. - DOI - PubMed
    1. Farmakis D, Triposkiadis F, Lekakis J, Parissis J. Heart failure in haemoglobinopathies: pathophysiology, clinical phenotypes, and management. European Journal of Heart Failure. 2017;19(4):479–489. doi: 10.1002/ejhf.708. - DOI - PubMed
    1. Romano MMD. Haemoglobinopathies from the cardiac point of view. Hematology, Transfusion and Cell Therapy. 2019;41(3):195–196. doi: 10.1016/j.htct.2019.05.002. - DOI - PMC - PubMed
    1. Hamideh D, Alvarez O. Sickle cell disease related mortality in the United States (1999–2009) Pediatric Blood and Cancer. 2013;60(9):1482–1506. doi: 10.1002/pbc.24557. - DOI - PubMed

MeSH terms

LinkOut - more resources